Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial

PURPOSE: In the multicenter, open-label, phase III FOWARC trial, modified infusional fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) plus radiotherapy resulted in a higher pathologic complete response rate than fluorouracil plus radiotherapy in Chinese patients with locally advanced rectal canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Yanhong, Chi, Pan, Lan, Ping, Wang, Lei, Chen, Weiqing, Cui, Long, Chen, Daoda, Cao, Jie, Wei, Hongbo, Peng, Xiang, Huang, Zonghai, Cai, Guanfu, Zhao, Ren, Huang, Zhongcheng, Xu, Lin, Zhou, Hongfeng, Wei, Yisheng, Zhang, Hao, Zheng, Jian, Huang, Yan, Zhou, Zhiyang, Cai, Yue, Kang, Liang, Huang, Meijin, Wu, Xiaojian, Peng, Junsheng, Ren, Donglin, Wang, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881102/
https://www.ncbi.nlm.nih.gov/pubmed/31557064
http://dx.doi.org/10.1200/JCO.18.02309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881102/
https://www.ncbi.nlm.nih.gov/pubmed/31557064
http://dx.doi.org/10.1200/JCO.18.02309

Ejemplares similares